8 results match your criteria: "From the University of Colorado Anschutz Medical Campus.[Affiliation]"
Long-Term Complications in Youth-Onset Type 2 Diabetes.
N Engl J Med
July 2021
From the University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora (P.B., P.Z.); George Washington University, Rockville, MD (K.L.D., B.T.); Yale University, New Haven, CT (S.C.); Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland (R.G.-K.); the Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston (D.M.N.); the University of Oklahoma Health Sciences Center, Oklahoma City (J.T.); and Washington University School of Medicine, St. Louis (N.H.W.).
Background: The prevalence of type 2 diabetes in youth is increasing, but little is known regarding the occurrence of related complications as these youths transition to adulthood.
Methods: We previously conducted a multicenter clinical trial (from 2004 to 2011) to evaluate the effects of one of three treatments (metformin, metformin plus rosiglitazone, or metformin plus an intensive lifestyle intervention) on the time to loss of glycemic control in participants who had onset of type 2 diabetes in youth. After completion of the trial, participants were transitioned to metformin with or without insulin and were enrolled in an observational follow-up study (performed from 2011 to 2020), which was conducted in two phases; the results of this follow-up study are reported here.
Objectives: Children visiting emergency departments (EDs) are disproportionately affected by mental health disorders. Integrated behavioral health models hold promise for improving care among ED patients. We implemented and evaluated a novel behavioral health service integrated psychology trainees in a safety net hospital's pediatric ED and urgent care.
View Article and Find Full Text PDFPediatric Syncope: A Systematic Review.
Pediatr Emerg Care
September 2020
Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
Objectives: The aims of the study were to perform the first systematic review of pediatric syncope etiologies and to determine the most common diagnoses with credible intervals (CredIs).
Methods: Review was performed within Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines and used Embase, Scopus, PubMed, and the Cochrane Controlled Trial databases. The following inclusion criteria for the articles were used: minimum of 10 patients, standard definition of syncope used, subjects who were 21 years or younger, and subjects who were either a consecutive retrospective group or a prospective group.
Strategies for Achieving Healthy Vascular Aging.
Hypertension
March 2018
From the University of Colorado Anschutz Medical Campus, Aurora (K.L.N., M.C.); and University of Colorado Boulder (M.J.R., D.R.S.).
Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Circulation
September 2014
From the University of Colorado Anschutz Medical Campus, Aurora, CO (R.T.B., P.N.P., W.S.T., P.D.V., F.A.M.); the Department of Medicine, Denver Health and Hospital Authority, Denver, CO (P.N.P.); Colorado Cardiovascular Outcomes Research (C-COR) Consortium, Denver, CO (P.N.P., P.D.V., F.A.M.); Marshfield Clinic Research Foundation, Marshfield, WI (R.G.); VA Palo Alto Health Care System, Palo Alto, Stanford University, Stanford, CA (P.A.H.); the Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (Y.W., J.P.C.); VA Eastern Colorado Healthcare System, Denver, CO (P.D.V.); and Novant Heart and Vascular Institute, Charlotte, NC (M.S.K.).
Background: Contemporary patterns of use and outcomes of implantable cardioverter-defibrillators (ICDs) in community practice settings are not well characterized. We assessed temporal trends in patient characteristics and outcomes among older patients undergoing primary prevention ICD therapy in US hospitals between 2006 and 2010.
Methods And Results: Using the National Cardiovascular Data Registry's ICD Registry, we identified Medicare fee-for-service beneficiaries aged ≥65 years and older with left ventricular ejection fraction ≤35% who underwent primary prevention ICD implantation, including those receiving concomitant cardiac resynchronization therapy between 2006 and 2010 and could be matched to Medicare claims.
Background: Tissue expander placement is a common means of reconstruction after mastectomy. Many patients report significant pain and discomfort with the tissue expansion process. Because placement is subpectoral, it was hypothesized that injection of the pectoralis muscle with botulinum toxin could decrease pain associated with tissue expanders.
View Article and Find Full Text PDF